Renaissance Technologies - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$21,016,000
+38.5%
134,700
+28.2%
0.02%
+20.0%
Q1 2020$15,170,000
-69.3%
105,100
-56.6%
0.02%
-60.5%
Q4 2019$49,493,000
+788.4%
242,100
+143.8%
0.04%
+533.3%
Q4 2018$5,571,000
+249.5%
99,300
+409.2%
0.01%
+200.0%
Q3 2018$1,594,000
+43.1%
19,502
-44.6%
0.00%
+100.0%
Q2 2017$1,114,000
+99.3%
35,200
+42.7%
0.00%0.0%
Q1 2017$559,00024,6700.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders